TI
ACET icon

Telemetry Investments’s Adicet Bio ACET Stock Holding History

Telemetry Investments’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$192K Sell
1,344
-65
-5% -$16.2K 0.3% 73
2022
Q3 		$321K Sell
1,409
-247
-15% -$62.7K 0.41% 65
2022
Q2 		$387K Buy
+1,656
New +$364K 0.46% 70

Other funds holding ACET

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Telemetry Investments's ACET Position: Q4 2022 in Review

Telemetry Investments reduced its Adicet Bio (ACET) stake by 4.6% in Q4 2022, selling an estimated $16.2K and leaving 1,344 shares worth $192K. The position accounts for 0.3% of the portfolio, ranked #73.

Telemetry Investments first reported a position in ACET in Q2 2022 and has held it in 3 quarters since. The position peaked at $387K in Q2 2022. 99 funds tracked by Wall St. Rank hold ACET as of Q4 2022.

  • Telemetry Investments held 1,344 shares of Adicet Bio worth $192K as of Q4 2022.
  • Telemetry Investments sold 65 Adicet Bio shares in Q4 2022, an estimated $16.2K.
  • Adicet Bio made up 0.3% of Telemetry Investments's portfolio in Q4 2022, its #73 holding.
  • Telemetry Investments first reported a position in Adicet Bio in Q2 2022 and has held it in 3 quarters since.
  • Telemetry Investments's Adicet Bio position peaked at $387K in Q2 2022.
  • 99 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.